Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging

Abstract

Bone marrow stromal cells isolated from a model of osteogenesis imperfecta (oim) mice, were transduced with a retrovirus (BAG) carrying the LacZ and neor genes after passage 21. The transduced cells retained the ability to express alkaline phosphatase activity in vitro when treated with recombinant human bone morphogenetic protein two (rhBMP-2), formed cartilage in vitro in aggregate cultures and formed bone in ceramic cubes after 6 weeks of implantation in nude mice. X-gal staining of ceramic cubes seeded with the transduced cells demonstrated the presence of LacZ-positive cells on the edges of bone and also in the lacunae of the newly formed bone 6 weeks after implantation. After infusion into femurs of oim mice, the transduced cells were detected in the marrow cavity and on the edges of the trabecular bone of the injected and contralateral femurs by X-gal staining and PCR analysis at 4, 10, 20, 30 and 40 days after injection. The LacZ gene was also detected in the lung and liver of the recipient mice at 4 and 10 days after injection but not at later time-periods. The present findings suggest that long-term cultured bone marrow stromal cells from osteogenesis imperfecta (OI) animals have the potential to traffic through the circulatory system, home to bone, form bone and continue to express exogenous genes. These findings open the possibility of using these cells as vehicles to deliver normal genes to bone as an alternative approach for the treatment of some forms of OI and certain other bone acquired and genetic diseases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Kuivaniemi H, Tromp GA, Prockop DL . Mutations in collagen genes: causes of rare and some common diseases in humans FASEB 1991 5: 2050–2052

    Article  Google Scholar 

  2. Byers PH . Disorders of collagen biosynthesis and structure. In: Scriver CR, Beander AL, Sly WS, Valle D (eds). The Metabolic Basis of Inherited Disease, 6th edn McGraw-Hill: NY, pp 2805–2842

  3. Prockop DJ . Mutations in collagen genes as a cause of connective tissue diseases New Engl J Med 1992 326: 540–546

    Article  CAS  Google Scholar 

  4. Niyibizi C, Byers PH, Bonadio J, Eyre DR . Incorporation level of a mutant collagen α2(I) chain (Gly580-Asp) into bone matrix in a lethal case of osteogenesis imperfecta J Biol Chem 1992 25: 23108–23112

    Google Scholar 

  5. Byers PH, Pyritz RE, Uitto J . Research perspectives in heritable disorders of connective tissue Matrix 1992: 333–342

  6. Shapiro JR, Chapman SD . Osteogenesis imperfecta. In: Kang A, Nimni ME (eds). Collagen, Vol. 5 Pathobiochemistry CRC Press: Boca Raton, pp 49–85

  7. Pereira RF et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage and lung in irradiated mice Proc Natl Acad Sci USA 1995 92: 4857–4861

    Article  CAS  Google Scholar 

  8. Prockop DJ, Kiviriko KI . Collagens: molecular biology and potentials for therapy Ann Rev Biochem 1995 64: 403–434

    Article  CAS  Google Scholar 

  9. Colige A et al. Use of antisense oligonucleotides to inhibit expression of mutated human procollagen gene (COL1A1(I)) in transfected mouse 3T3 cells Biochemistry 1993 32: 7–11

    Article  CAS  Google Scholar 

  10. Laptev AV, Lu Z, Colige A, Prockop DJ . Specific inhibition of a human collagen gene (COL1A1(I) with modified antisense oligonucleotides. The most effective target sites are clustered in double stranded regions of the predicted secondly structure for mRNA Biochemistry 1994 33: 11033–11039

    Article  CAS  Google Scholar 

  11. Wang Q, Marini JC . Antisense oligonucleotides selectively suppress expression of the mutant α2(I) collagen allele in type IV osteogenesis imperfecta fibroblasts J Clin Invest 1995 97: 448–454

    Article  Google Scholar 

  12. Chipman SD et al. Defective proα2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta Proc Natl Acad Sci USA 1993 90: 1701–1705

    Article  CAS  Google Scholar 

  13. Crystal R . Transfer of genes to humans early lessons and obstacles to success Science 1995 270: 404–410

    Article  CAS  Google Scholar 

  14. Evans CH, Robbins PD . Possible orthopaedic applications of gene therapy J Bone Joint Surg 1995 77A: 1103–1114

    Article  Google Scholar 

  15. Friedenstein AJ, Chailakhjan RK, Lalykina KS . The development of fibroblasts colonies in monolayer cultures of guinea pig bone marrow and spleen cells Cell Tissue Kinet 1970 3: 393–403

    CAS  PubMed  Google Scholar 

  16. Friedenstein AJ . Precursor cells of mechanocytes Int Rev Cytol 1976 47: 327–359

    Article  CAS  Google Scholar 

  17. Benayahu D et al. Bone marrow-derived stromal cell line expressing osteoblastic phenotype in vitro and osteogenic capacity in vivo J Cell Physiol 1989 140: 1–7

    Article  CAS  Google Scholar 

  18. Owen M . Marrow stromal cells J Cell Sci 1988 10: 63–76

    Article  CAS  Google Scholar 

  19. Prockop DJ . Marrow stromal cells as stem cells for nonhematopoetic tissues Science 1997 276: 71–74

    Article  CAS  Google Scholar 

  20. Caplan AI . Messenchymal stem cells J Orthop Res 1991 9: 641–650

    Article  CAS  Google Scholar 

  21. Aubin JE, Turksen K, Heersche JNM . Osteoblastic lineage. In: Noda M. Cellular and Molecular Biology of Bone Academic Press: San Diego, 1993, pp 1–45

  22. Beresford JN . Osteogenic stem cells and the stromal system Clin Orthopaedics Rel Res 1989 240: 270–279

    Google Scholar 

  23. Balk ML et al. Effect of rhBMP-2 on osteogenic potential of bone marrow stromal cells from an osteogenesis imperfecta (oim) mouse Bone 1977 21: 7–15

    Article  Google Scholar 

  24. Kamalia N, McCulloch CAG, Tanebaum HC, Linback H . Dexamethasone recruitment of self-renewing osteoprogenitor cells in chick bone marrow stromal cell cultures Blood 1992 79: 320–326

    CAS  PubMed  Google Scholar 

  25. Simmons DJ et al. Partial characterization of rat marrow stromal cells Calcif Tissue Int 1991 48: 326–334

    Article  CAS  Google Scholar 

  26. Thies R et al. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells Endorcinology 1992 130: 1318–1324

    CAS  Google Scholar 

  27. Vukicevic S, Luyten FP, Reddi AH . Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin 2 Proc Natl Acad Sci USA 1989 86: 8793–8797

    Article  CAS  Google Scholar 

  28. Pitaru S, Kotev-Emeth S, Noff D, Savion N . Basic fibroblast growth factor (BFGF) enhances the capacity of rat bone stromal bone marrow cells to form mineralized bone-like tissue in culture. J Bone Miner Res 1990; 5 (Suppl 2) S78

  29. Dennis JE, Caplan AI . Porous ceramic vehicles for rat marrow-derived osteogenic cell delivery: effects of pre-treatment with fibronectin or laminin J Oral Implantol 1993 19: 106–115

    CAS  PubMed  Google Scholar 

  30. Allay J et al. LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow derived human osteogenic mesenchymal progenitors Hum Gene Ther 1997 8: 1417–1427

    Article  CAS  Google Scholar 

  31. Price J, Turner D, Cepko C . Lineage analysis in the vertebrate nervous system by retrovirus mediated gene transfer Proc Natl Acad Sci USA 1987 84: 156–160

    Article  CAS  Google Scholar 

  32. Johnstone B et al. In vitro chondrogenesis of bone marrow derived mesenchymal progenitor cells Exp Cell Res 1998 238: 265–272

    Article  CAS  Google Scholar 

  33. Kato Y et al. Terminal differentiation and calcification in rabbit chondrocyte cultures grown in centrifugre tubes: regulation by transforming growth factor β and serum factors Proc Natl Acad Sci USA 1988 85: 9552–9556

    Article  CAS  Google Scholar 

  34. Ballock TR, Reddi AH . Thyroxine is the serum factor that regulates morphogenesis of columnar cartilage from isolated chondrocytes in chemically defined medium J Cell Biol 1994 126: 1311–1318

    Article  CAS  Google Scholar 

  35. Cassiede P, Dennis J, Ma F, Caplan AI . Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGFβ1 or PDGF-BB as assayed in vivo and in vitro J Bone Miner Res 1996 11: 1264–1273

    Article  CAS  Google Scholar 

  36. Sanes JR, Rubenstain JLT, Nicolas JF . Use of recombinant retrovirus to study post-implantation cell lineage in mouse embryos EMBO J 1986 5: 3133–3142

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oyama, M., Tatlock, A., Fukuta, S. et al. Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging. Gene Ther 6, 321–329 (1999). https://doi.org/10.1038/sj.gt.3300839

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3300839

Keywords

This article is cited by

Search

Quick links